Sonoma Biotherapeutics is a private drug discovery company. It has raised $265 million across 1 recorded round; the latest was a $265 million Series B in Aug 2021.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$265.0M
Last round
Early Stage VC (Series B)
Aug 2021
Team — not yet on record
No current team members for Sonoma Biotherapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sonoma Biotherapeutics with a free account
·Watch Sonoma Biotherapeutics: the Monday email on marks, rounds and moves
